Studies from Sechenov First Moscow State Medical University in the Area of Atrial Fibrillation Described (New Possibilities of Antiarrhythmic Therapy of Atrial Fibrillation: a Review).

A new study from Sechenov First Moscow State Medical University in Russia explores the possibilities of antiarrhythmic therapy for atrial fibrillation (AF), the most common heart rhythm disorder. The study highlights three main treatment directions for AF: anticoagulant therapy, control of arrhythmia symptoms, and treatment of concomitant diseases and risk factors. The research discusses various strategies for rhythm control, including cardioversion, long-term antiarrhythmic therapy, and radiofrequency catheter ablation. The study also emphasizes the ongoing search for new drugs to prevent and treat AF at the molecular level. [Extracted from the article]